Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study. - Test2 - elhamkhani - TriplyDB

Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.

Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.

http://www.wikidata.org/entity/Q35567191

about

Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's disease Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease.Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease.A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease Monoamine reuptake inhibitors in Parkinson's disease.Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.The impact of depressive symptoms in early Parkinson disease.Management of the behavioral aspects of Parkinson's disease.Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.

P2860

Q28084380-4EF038F5-3C89-4ED5-9711-F78B71824E6D Q33533358-F16E58B0-AF2B-41E0-ADCE-922FC9F266D8 Q33857755-00F11639-53D8-446D-A764-AC5A3677B2ED Q34089583-F03821C0-01E4-471D-AC1E-8DC6D964A86A Q35043846-2407D0E3-A36A-4498-954B-BBCD36045968 Q35165280-5876ED6D-AA9C-4023-8821-F8D8DF87A3D3 Q35988441-B14AB219-04E0-4A99-9A4E-95C139A7D3A9 Q36074454-C9A2E6C8-34B1-4836-AF36-A8EAF6594061 Q36847271-875E99BE-C2A8-4BD2-BB12-724EE829C622 Q39311578-71B26565-6079-4EDF-B553-238C84817A76

P2860

Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.

http://www.wikidata.org/entity/Q35567191

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Escitalopram for major depress ...... -label, flexible-dosage study.

@ast

Escitalopram for major depress ...... -label, flexible-dosage study.

@en

type

label

Escitalopram for major depress ...... -label, flexible-dosage study.

@ast

Escitalopram for major depress ...... -label, flexible-dosage study.

@en

prefLabel

Escitalopram for major depress ...... -label, flexible-dosage study.

@ast

Escitalopram for major depress ...... -label, flexible-dosage study.

@en

P1433

Q35567191-7DAF5401-DF75-473F-B6F3-8D685A1F60B7

P1476

Q35567191-9B954415-345D-45AB-A066-4EAA5FC8D894

P2093

Q35567191-170644E4-E5F3-4534-A057-A1F86B1F3A0F

Q35567191-52379C95-59FE-446B-8824-A7EBC8748C85

Q35567191-6DB2DC28-15CD-4C78-B535-43BEB00F42E1

Q35567191-7BB9E6AA-0C8B-44B3-9A11-1DBFCD02AB06

Q35567191-ABBF1C35-9024-43EC-9910-59A4BABB24E0

Q35567191-CD460FE7-4538-46DC-9455-9486D1BBACF8

P2860

Q35567191-0E161BC1-FD43-4591-AFD0-22376141E76D

Q35567191-1380C89E-3CD6-4C37-98B3-8E0C88BD43C0

Q35567191-39744089-AF95-4E2A-9F7F-E3703B63A730

Q35567191-3BF6191C-ED17-4A44-84CE-912822B58D5C

Q35567191-3DE2776D-0736-45B2-861C-7F138830A154

Q35567191-533880B7-0DAA-40DB-BA03-C75B6379859D

Q35567191-5F86035E-FD18-4286-9A71-F6EF142F48B0

Q35567191-65A90C81-6535-4425-A824-183DA798259B

Q35567191-7BB6D607-72D0-4823-B51E-46CED00FFE4A

Q35567191-8915D065-41B0-4E16-81C4-608041969FD7

P304

Q35567191-056BB4A6-38FB-4810-9D2D-AC081050B108

P31

Q35567191-ABD1A2B2-C2C5-4BE2-A6A0-4C7BCD7F77EF

P356

Q35567191-FFB2401F-26E3-4AEE-AA36-CAD5E74D5ACC

P433

Q35567191-53668CE3-8F02-465A-85FB-C42EDC80460C

P478

Q35567191-36D99941-FFE6-46BC-97D3-2E6D0F9A3BF5

P577

Q35567191-B3FC8103-8B9A-4C5D-B0C1-6383A4B355A8

P698

Q35567191-DF4F38A7-587B-4B23-99A4-49C5308E0BC4

P921

Q35567191-FD66A08C-956D-4AAC-90C9-A6C707050ABF

P932

Q35567191-1E7CEF51-4A6A-48B7-BAFB-43F336880BB4

P356

JNP.2006.18.3.377

P1433

Journal of Neuropsychiatry and Clinical Neurosciences

P1476

Escitalopram for major depress ...... -label, flexible-dosage study.

@en

P2093

Daniel Weintraub

http://www.w3.org/2001/XMLSchema#string

Donna Taraborelli

http://www.w3.org/2001/XMLSchema#string

Ira R Katz

http://www.w3.org/2001/XMLSchema#string

John E Duda

http://www.w3.org/2001/XMLSchema#string

Knashawn H Morales

http://www.w3.org/2001/XMLSchema#string

Matthew B Stern

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

A self report measure of affective lability

“Mini-mental state”

The neuropsychiatry of pathologic affect: an approach to evaluation and treatment

Parkinsonism: onset, progression and mortality

"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review

The assessment of anxiety states by rating

Diagnostic criteria for Parkinson disease.

Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa

Depression in Parkinson's disease: conceptual issues and clinical challenges.

P304

377-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/JNP.2006.18.3.377

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16963587

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

1761053

http://www.w3.org/2001/XMLSchema#string